Tiny study peers inside finger joints to unlock RA bone erosion secrets
NCT ID NCT04645381
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at bone erosions in the finger joints of 9 people with rheumatoid arthritis. Researchers use advanced imaging and tissue analysis to see tiny blood vessels and bone structure. The goal is to better understand how joint damage happens, which could lead to better monitoring in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors monitor bone damage in rheumatoid arthritis patients.
- What could go wrong
- This is a very small, early observational study with only 9 participants, so findings may not apply broadly. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
9 people
The number who actually took part.
- Started
-
Nov 2020
- Expected to finish
-
Nov 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants with RA are recruited in conjunction with a routine visit at the Department of Orthopedic Surgery at Aarhus University Hospital or at the Regional Hospital Holstebro for assessment of surgical indication for joint replacement surgery on MCP joints by a specialist in orthopedic surgery.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
RA Participants: Inclusion Criteria: * Age \> 18 years * Participants diagnosed with RA according to the ACR/EULAR (2010) classification criteria or American Rheumatism Association 1987 revised criteria for the patients who were diagnosed before 2010. * Indication for prosthesis surgery with total joint replacement of the MCP joint according to the clinical procedure (often radiological signs of OA in the MCP joint, joint pain, angular deformity and/or impairment of daily functions). Exclusion Criteria: * Unable to give written informed consent. * Active malignant disease, hypercalcemia, poor kidney function (estimated glomerular filtration rate \< 35 mL/min), untreated hypo-/hyperthyroidism, pregnancy or wish thereof, previously fracture/dislocation of the investigated joint or metal prosthesis in joints of the investigated hand. Bone sample will be excluded from analysis, if the following is present: \- Bone not adequate for analysis (fractured bone samples).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthritis rheumatoid are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus, Central Region of Denmark, 8200, Denmark
-
Regional Hospital Holstebro
Holstebro, Central Region of Denmark, 7500, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cementless hip stem hold up in asian patients?
- Immune cell study could pave way for new arthritis treatments
- Are women with autoimmune diseases getting the gynecological care they need?
- Brain scans may predict who gets long-term pain from arthritis
- Can mindfulness ease arthritis pain? small study seeks answers
- Can a simple blood test help rheumatoid arthritis patients get the right drug?